Linkage of tyrosine kinase activity with transforming ability of the p185neu oncoprotein - PubMed (original) (raw)
. 1989 Oct;4(10):1175-83.
Affiliations
- PMID: 2571965
Linkage of tyrosine kinase activity with transforming ability of the p185neu oncoprotein
D B Weiner et al. Oncogene. 1989 Oct.
Abstract
The neu oncogene encodes a 185 kd glycoprotein (p185neu) with intrinsic tyrosine kinase activity. Sequencing data has demonstrated that oncogenic p185neu differs from c-neu by a single point mutation within the transmembrane region of the glycoprotein. This mutation results in the substitution of a glutamic acid residue for a nonpolar valine residue at amino acid position 664 of the rat neu gene product. Recent studies have demonstrated that this mutation results in specific aggregation of the p185neu oncoprotein mimicking ligand induced dimerization events. The cellular consequences of the aggregated phenotype may include the enzymatic activation of p185neu. We demonstrate that the oncoprotein p185neu possesses higher intrinsic tyrosine kinase activity and that this increase in enzymatic activity is apparent within the plasma membrane, manifesting itself through the increased tyrosine phosphorylation of substrates. Furthermore, the neu oncoprotein itself is also phosphorylated on tyrosine to a higher extent than the proto-oncoprotein. These results strongly link enzymatic activation of p185neu to cellular transformation events. To test directly the effect of p185neu tyrosine kinase activity on cellular transformation we constructed mutant p185neu devoid of ATP binding ability. This mutant protein is expressed at high levels, but is unable to induce the transforming phenotype. The point mutation within the transmembrane region of p185neu mimics aspects of ligand induced activation events including increases in the specific tyrosine kinase activity of the molecule leading to cellular transformation.
Similar articles
- A point mutation in the neu oncogene mimics ligand induction of receptor aggregation.
Weiner DB, Liu J, Cohen JA, Williams WV, Greene MI. Weiner DB, et al. Nature. 1989 May 18;339(6221):230-1. doi: 10.1038/339230a0. Nature. 1989. PMID: 2654648 - The role of the neu oncogene product in cell transformation and normal development.
Kokai Y, Wada T, Myers JN, Brown VI, Dobashi K, Cohen J, Hamuro J, Weiner DB, Greene MI. Kokai Y, et al. Princess Takamatsu Symp. 1988;19:45-57. Princess Takamatsu Symp. 1988. PMID: 2908355 Review. - Constitutively activated neu oncoprotein tyrosine kinase interferes with growth factor-induced signals for gene activation.
Lehtola L, Sistonen L, Koskinen P, Lehväslaiho H, Di Renzo MF, Comoglio PM, Alitalo K. Lehtola L, et al. J Cell Biochem. 1991 Jan;45(1):69-81. doi: 10.1002/jcb.240450114. J Cell Biochem. 1991. PMID: 1706346 - Absence of autophosphorylation site Y882 in the p185neu oncogene product correlates with a reduction of transforming potential.
Zhang HT, O'Rourke DM, Zhao H, Murali R, Mikami Y, Davis JG, Greene MI, Qian X. Zhang HT, et al. Oncogene. 1998 Jun 4;16(22):2835-42. doi: 10.1038/sj.onc.1201820. Oncogene. 1998. PMID: 9671404 - The neu-oncogene: signal transduction pathways, transformation mechanisms and evolving therapies.
Dougall WC, Qian X, Peterson NC, Miller MJ, Samanta A, Greene MI. Dougall WC, et al. Oncogene. 1994 Aug;9(8):2109-23. Oncogene. 1994. PMID: 7913542 Review.
Cited by
- Heteromeric Solute Carriers: Function, Structure, Pathology and Pharmacology.
Fairweather SJ, Shah N, Brӧer S. Fairweather SJ, et al. Adv Exp Med Biol. 2021;21:13-127. doi: 10.1007/5584_2020_584. Adv Exp Med Biol. 2021. PMID: 33052588 Review. - B1 oligomerization regulates PML nuclear body biogenesis and leukemogenesis.
Li Y, Ma X, Chen Z, Wu H, Wang P, Wu W, Cheng N, Zeng L, Zhang H, Cai X, Chen SJ, Chen Z, Meng G. Li Y, et al. Nat Commun. 2019 Aug 22;10(1):3789. doi: 10.1038/s41467-019-11746-0. Nat Commun. 2019. PMID: 31439836 Free PMC article. - ERBB2 signaling drives supporting cell proliferation in vitro and apparent supernumerary hair cell formation in vivo in the neonatal mouse cochlea.
Zhang J, Wang Q, Abdul-Aziz D, Mattiacio J, Edge ASB, White PM. Zhang J, et al. Eur J Neurosci. 2018 Nov;48(10):3299-3316. doi: 10.1111/ejn.14183. Epub 2018 Oct 24. Eur J Neurosci. 2018. PMID: 30270571 Free PMC article. - Genetically engineered mouse models shed new light on the pathogenesis of neurofibromatosis type I-related neoplasms of the peripheral nervous system.
Brossier NM, Carroll SL. Brossier NM, et al. Brain Res Bull. 2012 May 1;88(1):58-71. doi: 10.1016/j.brainresbull.2011.08.005. Epub 2011 Aug 10. Brain Res Bull. 2012. PMID: 21855613 Free PMC article. Review. - Targeting erbB receptors.
Cai Z, Zhang H, Liu J, Berezov A, Murali R, Wang Q, Greene MI. Cai Z, et al. Semin Cell Dev Biol. 2010 Dec;21(9):961-6. doi: 10.1016/j.semcdb.2010.09.005. Epub 2010 Sep 17. Semin Cell Dev Biol. 2010. PMID: 20850557 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous